# Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

> **NCT00456235** · PHASE4 · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 92 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Mycophénolate Mofétil
- **DRUG:** Ciclosporine A
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00456235
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-09
- **Final completion:** 2011-09
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456235, "Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00456235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*